456 related articles for article (PubMed ID: 27400643)
1. The antibiotic pipeline for multi-drug resistant gram negative bacteria: what can we expect?
Falagas ME; Mavroudis AD; Vardakas KZ
Expert Rev Anti Infect Ther; 2016 Aug; 14(8):747-63. PubMed ID: 27400643
[TBL] [Abstract][Full Text] [Related]
2. Novel β-lactam-β-lactamase inhibitor combinations: expectations for the treatment of carbapenem-resistant Gram-negative pathogens.
Karaiskos I; Galani I; Souli M; Giamarellou H
Expert Opin Drug Metab Toxicol; 2019 Feb; 15(2):133-149. PubMed ID: 30626244
[TBL] [Abstract][Full Text] [Related]
3. Developments on antibiotics for multidrug resistant bacterial Gram-negative infections.
Voulgaris GL; Voulgari ML; Falagas ME
Expert Rev Anti Infect Ther; 2019 Jun; 17(6):387-401. PubMed ID: 31006284
[No Abstract] [Full Text] [Related]
4. Treatment of urinary tract infections in the era of antimicrobial resistance and new antimicrobial agents.
Bader MS; Loeb M; Leto D; Brooks AA
Postgrad Med; 2020 Apr; 132(3):234-250. PubMed ID: 31608743
[TBL] [Abstract][Full Text] [Related]
5. A resurgence of β-lactamase inhibitor combinations effective against multidrug-resistant Gram-negative pathogens.
Bush K
Int J Antimicrob Agents; 2015 Nov; 46(5):483-93. PubMed ID: 26498989
[TBL] [Abstract][Full Text] [Related]
6. [New Antibiotics for Treatment of Highly Resistant Gram-negative Bacteria].
Probst-Kepper M; Geginat G
Anasthesiol Intensivmed Notfallmed Schmerzther; 2018 Jul; 53(7-08):529-542. PubMed ID: 30036899
[TBL] [Abstract][Full Text] [Related]
7. New agents for the treatment of infections with Gram-negative bacteria: restoring the miracle or false dawn?
Wright H; Bonomo RA; Paterson DL
Clin Microbiol Infect; 2017 Oct; 23(10):704-712. PubMed ID: 28893690
[TBL] [Abstract][Full Text] [Related]
8. Infections by multidrug-resistant Gram-negative Bacteria: What's new in our arsenal and what's in the pipeline?
Koulenti D; Song A; Ellingboe A; Abdul-Aziz MH; Harris P; Gavey E; Lipman J
Int J Antimicrob Agents; 2019 Mar; 53(3):211-224. PubMed ID: 30394301
[TBL] [Abstract][Full Text] [Related]
9. Spotlight on ceftazidime/avibactam: a new option for MDR Gram-negative infections.
Falcone M; Paterson D
J Antimicrob Chemother; 2016 Oct; 71(10):2713-22. PubMed ID: 27432599
[TBL] [Abstract][Full Text] [Related]
10. The β-Lactams Strike Back: Ceftazidime-Avibactam.
Zasowski EJ; Rybak JM; Rybak MJ
Pharmacotherapy; 2015 Aug; 35(8):755-70. PubMed ID: 26289307
[TBL] [Abstract][Full Text] [Related]
11. Imipenem-Cilastatin-Relebactam: A Novel β-Lactam-β-Lactamase Inhibitor Combination for the Treatment of Multidrug-Resistant Gram-Negative Infections.
Smith JR; Rybak JM; Claeys KC
Pharmacotherapy; 2020 Apr; 40(4):343-356. PubMed ID: 32060929
[TBL] [Abstract][Full Text] [Related]
12. Will new antimicrobials overcome resistance among Gram-negatives?
Bassetti M; Ginocchio F; Mikulska M; Taramasso L; Giacobbe DR
Expert Rev Anti Infect Ther; 2011 Oct; 9(10):909-22. PubMed ID: 21973303
[TBL] [Abstract][Full Text] [Related]
13. Recent developments in antibiotic agents for the treatment of complicated intra-abdominal infections.
Lin SY; Huang CH; Ko WC; Chen YH; Hsueh PR
Expert Opin Pharmacother; 2016; 17(3):339-54. PubMed ID: 26610040
[TBL] [Abstract][Full Text] [Related]
14. Can octapeptin antibiotics combat extensively drug-resistant (XDR) bacteria?
Blaskovich MAT; Pitt ME; Elliott AG; Cooper MA
Expert Rev Anti Infect Ther; 2018 Jun; 16(6):485-499. PubMed ID: 29848132
[TBL] [Abstract][Full Text] [Related]
15. New perspectives in the antibiotic treatment of mechanically ventilated patients with infections from Gram-negatives.
Karvouniaris M; Pontikis K; Nitsotolis T; Poulakou G
Expert Rev Anti Infect Ther; 2021 Jul; 19(7):825-844. PubMed ID: 33270485
[No Abstract] [Full Text] [Related]
16. In vitro susceptibility of characterized β-lactamase-producing Gram-negative bacteria isolated in Japan to ceftazidime-, ceftaroline-, and aztreonam-avibactam combinations.
Yoshizumi A; Ishii Y; Aoki K; Testa R; Nichols WW; Tateda K
J Infect Chemother; 2015 Feb; 21(2):148-51. PubMed ID: 25444674
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial resistance and treatment: an unmet clinical safety need.
Bassetti M; Russo A; Carnelutti A; La Rosa A; Righi E
Expert Opin Drug Saf; 2018 Jul; 17(7):669-680. PubMed ID: 29897796
[TBL] [Abstract][Full Text] [Related]
18. What's new in the treatment of multidrug-resistant gram-negative infections?
Mo Y; Lorenzo M; Farghaly S; Kaur K; Housman ST
Diagn Microbiol Infect Dis; 2019 Feb; 93(2):171-181. PubMed ID: 30224228
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial Resistance in the Intensive Care Unit: A Focus on Gram-Negative Bacterial Infections.
MacVane SH
J Intensive Care Med; 2017 Jan; 32(1):25-37. PubMed ID: 26772199
[TBL] [Abstract][Full Text] [Related]
20. New antibiotics and antimicrobial combination therapy for the treatment of gram-negative bacterial infections.
Bassetti M; Righi E
Curr Opin Crit Care; 2015 Oct; 21(5):402-11. PubMed ID: 26263298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]